Corticolimbic gray matter loss in Parkinson's disease without dementia

European Journal of Neurology

Volumn 17, Issue 8, 2010, Pages 1090-1097

  Nishio, Y ^a   Hirayama, K ^a   Takeda, A ^a   Hosokai, Y ^a   Ishioka, T ^a   Suzuki, K ^a,b   Itoyama, Y ^a   Takahashi, S ^a   Mori, E ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

cerebral cortex; cognitive impairment; medial temporal lobe; mild cognitive impairment; parkinson's disease; voxel based morphometry

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LIMBIC SYSTEM; MALE; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TEMPORAL LOBE; UNIFIED PARKINSON DISEASE RATING SCALE; BRAIN MAPPING; COMPLICATION; IMAGE PROCESSING; MIDDLE AGED; NERVE DEGENERATION; NONMYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; BRAIN MAPPING; CEREBRAL CORTEX; DEMENTIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS, UNMYELINATED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 77954629817     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.02980.x     Document Type: Article

References (32)

1. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003 2 : 229 237.
2. Farlow MR, Cummings J. A modern hypothesis: the distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease. Dement Geriatr Cogn Disord 2008 25 : 301 308.
3. Hosokai Y, Nishio Y, Hirayama K, et al. Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord 2009 24 : 854 862.
4. Huang C, Mattis P, Perrine K, et al. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008 70 : 1470 1477.
5. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005 20 : 1255 1263. (Pubitemid 41645899)
6. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007 22 : 1689 1707. quiz 837. (Pubitemid 47597592)
7. Emre M. Treatment of dementia associated with Parkinson's disease. Parkinsonism Relat Disord 2007 13 (Suppl. 3 S457 S461.
8. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000 11 : 805 821.
9. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993 39 : 165 172.
10. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997 9 (Suppl. 1 173 176. discussion 7-8.
11. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994 44 : 2308 2314.
12. Mori S, Mori E, Iseki E, Kosaka K. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. Psychiatry Clin Neurosci 2006 60 : 190 195.
13. Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983 19 : 448 450.
14. Fahn S, Elton R, Committee mot UD. Unified Parkinson's Disease Rating Scale.
15. Del Dotto P, Gambaccini G, Caneparo D, et al. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists. Neurol Sci 2003 24 : 170 171.
16. Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007 130 : 708 719.
17. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005 26 : 839 851.
18. Friston KJ, Penny WD, Glaser DE. Conjunction revisited. Neuroimage 2005 25 : 661 667.
19. Nichols T, Brett M, Andersson J, Wager T, Poline JB. Valid conjunction inference with the minimum statistic. Neuroimage 2005 25 : 653 660.
20. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005 58 : 773 776.
21. Hurtig HI, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000 54 : 1916 1921.
22. Good CD, Scahill RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002 17 : 29 46.
23. Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 2000 57 : 470 475.
24. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007 22 : 1272 1277.
25. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006 21 : 1343 1349.
26. Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord doi: [Epub ahead of print].
27. Levy G, Jacobs DM, Tang MX, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002 17 : 1221 1226.
28. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007 130 : 1787 1798.
29. Woods SP, Troster AI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc 2003 9 : 17 24.
30. Alladi S, Arnold R, Mitchell J, Nestor PJ, Hodges JR. Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile. Psychol Med 2006 36 : 507 515.
31. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007 78 : 254 259.
32. Keller SS, Wilke M, Wieshmann UC, Sluming VA, Roberts N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004 23 : 860 868.